Adam Zagoria covers basketball at all levels. He is the author of two books and an award-winning journalist whose articles have appeared in ESPN The Magazine, SLAM, Sheridan Hoops, Sports Illustrated, Basketball Times and in newspapers nationwide.
Arsalan Kazemi, a 6-foot-7 combo forward from The Patterson (N.C.) School, remains uncommitted after his weekend official visit to Seton Hall.
“Are we interested? Yes, we are,” Anthony Ibrahim, Kazemi’s adviser, saidin a phone interview. “Are we highly interested? Yes, we are highly interested? Did we like it? Yes, we did. We both liked it. The biggest thing that I saw was that [Seton Hall head coach Bobby] Gonzalez really wanted Arsalan and wanted him to commit now. He wanted him to get it over with, let the whole nation know that Arsalan Kazemi committed. That’s what they wanted to hear. I’m sorry we were not able to give them that, but we are definitely still very, very interested in them.”
Kazemi, hoping to become the first Iranian to play American college ball, will visit Rice next weekend and Maryland Nov. 8 for an exhibition.
Other schools remain interested but those are the only official visits yet set.
“We’re going to see what the future Hall of Famer Ben Braun [of Rice] brings to the table,” Ibrahim said. “And we’ve gotta see what Mr. Gary Williams thinks.”
More on this in a bit….
Adam Zagoria is a Basketball Insider who covers basketball at all levels. A contributor to The New York Times and SportsNet New York (SNY), he is also the author of two books and is an award-winning journalist and filmmaker. His articles have appeared in ESPN The Magazine, SLAM, Sheridan Hoops, Basketball Times and in newspapers nationwide. He also won an Emmy award for his work on the SNY mini-documentary on Syracuse guard Tyus Battle.
A veteran Ultimate Frisbee player, he has competed in numerous National and World Championships and, perhaps more importantly, his teams won the Westchester Summer League (WSL) championships in 2011 and 2013.
He lives in Manhattan with his wife and children.